Schedule 2 is a good result. I should think supermarkets with an in-house pharmacy could stock it.
And, just for you @Teddyward,
So, please, no more BS that it is, it might be, is probably, could possibly be - systemic. Because officially - it is not.
- Forums
- ASX - By Stock
- Interim decision to amend the Poison Standard for astodrimer sodium
Schedule 2 is a good result. I should think supermarkets with an...
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.5¢ | $35.24K | 364.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 18326 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 15262 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8326 | 0.095 |
3 | 160000 | 0.094 |
2 | 134306 | 0.092 |
3 | 81442 | 0.090 |
1 | 30000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 5000 | 1 |
0.100 | 38876 | 3 |
0.105 | 199768 | 2 |
0.110 | 168286 | 9 |
0.115 | 85453 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
SPL (ASX) Chart |